What is the minimum investment required for PCD Pharma Franchise?

The minimum investment typically ranges from ₹2–5 lakhs, depending on territory size, product selection and initial stock planning. Our team will help structure this based on your goals.

What documents are required to become a franchise partner?

You will need a valid Drug License, GST registration and basic KYC documents. Our team will guide you through every step of the documentation process.

What kind of support and training do you provide?

We provide product training, sales guidance, marketing materials, doctor coverage strategies, and ongoing business support through dedicated account managers.

How are territories allocated and protected?

Territories are allocated based on mutual agreement and market mapping. We offer genuine monopoly rights with clear documentation to avoid internal competition.

What is the expected profit margin and ROI timeline?

Average profit margins range from 25–30%, with typical ROI timelines between 12–18 months, depending on your execution and territory potential.

How do you ensure product quality and compliance?

All products are manufactured in WHO-GMP certified facilities with 100% quality testing, robust documentation and DCGI approvals as applicable.

What is the delivery timeline and process?

Dispatch timelines depend on order size and location, but we maintain a strong track record of timely delivery across India with proper packaging and logistics partners.

Antibiotics/Anti-infectives

STECIX LB 100

Cefixime 100mg + Lactic Acid Bacillus 60 Million Spores

Pack: 30ML
Format: With Carton

MRP₹130.00

A high-potency, dual-action antibacterial and probiotic formula designed for the intensive treatment of severe pediatric infections. STECIX LB 100 combines a double-strength third-generation cephalosporin with Lactic Acid Bacillus to eliminate resistant bacteria while shielding the child's digestive system from antibiotic-associated side effects.

About The Product

Key Benefits

Maximum Strength Antibacterial Action

Cefixime 100mg is a potent, double-strength third-generation cephalosporin that works by inhibiting bacterial cell wall synthesis. This higher concentration is specifically designed for older children or more severe cases, providing a robust clinical response against a wide range of Gram-positive and Gram-negative pathogens.

Synergistic Gut Microbiome Protection

The inclusion of Lactic Acid Bacillus (60 Million Spores) acts as a protective shield for the intestinal tract. Since high-dose antibiotics can often disrupt natural gut flora, this probiotic component works to replenish beneficial bacteria, maintaining a healthy microbial balance throughout the treatment course.

Prevention of Antibiotic-Associated Diarrhea (AAD)

Lactic Acid Bacillus spores are highly resilient and survive the acidic environment of the stomach to reach the intestines. By restoring the intestinal environment, STECIX LB 100 significantly reduces the risk of diarrhea, abdominal bloating, and cramping, which are common complications of intensive antibiotic therapy.

Intensive Management of Typhoid and Respiratory Infections

STECIX LB 100 is a gold-standard choice for the management of enteric (Typhoid) fever and complicated respiratory infections. Its superior tissue penetration ensures that the antibiotic reaches deep-seated infection sites in the lungs, ears, or intestines to rapidly eliminate harmful bacteria.

Superior Resistance Management

Cefixime remains exceptionally stable in the presence of beta-lactamase enzymes produced by resistant bacteria. This ensures that STECIX LB 100 remains active and potent where standard penicillins might fail, providing a reliable defense against tough, community-acquired pediatric pathogens.

Enhanced Recovery and Patient Compliance

By treating the infection and simultaneously preventing gastrointestinal distress, STECIX LB 100 ensures a much smoother recovery process. The concentrated 100mg dose allows for a smaller volume of syrup per administration, making it easier for children to complete their full therapeutic cycle.

Indication Severe Typhoid (Enteric) Fever, Complicated Acute Otitis Media, Chronic Tonsillitis and Pharyngitis, Resistant Urinary Tract Infections (UTIs), Lower Respiratory Tract Infections, Prevention of Antibiotic-Induced Gastric Upset.

Indications

Severe Typhoid (Enteric) Fever
Complicated Acute Otitis Media
Chronic Tonsillitis and Pharyngitis
Resistant Urinary Tract Infections (UTIs)
Lower Respiratory Tract Infections
Prevention of Antibiotic-Induced Gastric Upset.

Product descriptions, dosage forms, and compositions listed on the website are for reference by licensed practitioners and distributors only.

STECIX LB 100